|
HS Code |
451103 |
| Product Name | Butylated Hydroxytoluene Veterinary Grade API |
| Chemical Formula | C15H24O |
| Cas Number | 128-37-0 |
| Appearance | White or pale yellow crystalline powder |
| Molecular Weight | 220.35 g/mol |
| Solubility | Insoluble in water, soluble in organic solvents like ethanol and acetone |
| Main Usage | Antioxidant in veterinary medicines |
| Pharmacopoeia Standard | Complies with relevant veterinary grade standards |
| Purity | Typically ≥99% |
| Storage Conditions | Store in a cool, dry place away from sunlight |
| Shelf Life | 2-3 years if stored properly |
| Dosage Forms Supported | Tablets, injections, capsules, powders, granules, premix, solutions |
As an accredited Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packed in 25 kg fiber drums with inner double polyethylene bags, labeled for veterinary use; protects from moisture, light, and contamination. |
| Shipping | Shipping for Butylated Hydroxytoluene Veterinary Grade API is conducted in compliance with international regulations, ensuring secure, moisture-proof, and tamper-evident packaging. The product is shipped in sealed fiber drums or HDPE containers with inner liners, suitable for tablets, injections, capsules, powders, granules, premix, and solutions. Temperature and transit conditions are carefully monitored. |
| Storage | **Storage Description:** Store Butylated Hydroxytoluene Veterinary Grade API in tightly closed containers, protected from light, moisture, and heat. Keep in a cool, dry, and well-ventilated area below 25°C. Separate from incompatible substances. Ensure containers are clearly labeled and positioned to prevent contamination, especially when used for tablets, injections, capsules, powders, granules, premix, or solutions. |
|
Purity 99%: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with 99% purity is used in the formulation of oral dosage forms, where it ensures maximal antioxidant protection of active pharmaceutical ingredients. Melting Point 70°C: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with a melting point of 70°C is used in injectable veterinary solutions, where it maintains compound stability during autoclaving processes. Particle Size D90 <150 µm: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with particle size D90 less than 150 µm is used in granule and premix manufacturing, where it promotes uniform distribution and homogeneity within premixes. Stability Temperature up to 60°C: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions stable up to 60°C is used in heat-processed veterinary powders, where it preserves antioxidant efficacy throughout production and storage. Viscosity Grade Low: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions of low viscosity grade is used in oral solution formulations, where it allows easy dispersion and rapid dissolution. Moisture Content <0.5%: Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content below 0.5% is used in the manufacture of capsules and tablets, where it enhances product shelf-life and prevents degradation. |
Competitive Butylated Hydroxytoluene Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Our facility produces Butylated Hydroxytoluene (BHT) at the Active Pharmaceutical Ingredient (API) grade, meeting veterinary standards for tablet, injection, capsule, powder, granule, premix, and solution formulations. Over decades of hands-on production, we have seen animal health professionals rely on BHT for its stabilizing role in various dosage forms. Our team stands behind every shipment with full traceability, batch testing, and documented consistency. Quality assurance starts at the raw material level and continues through each synthesis and purification step—there’s no shortcut if veterinary care depends on it.
Working with BHT in the veterinary sector calls for close attention to specs that directly affect real-world performance. Our typical API is manufactured with a purity profile meeting no less than 99% by HPLC, and residual solvents stay below pharmacopeia thresholds. Appearance is always clear, white, and crystalline. Particle size controls—between 80 and 140 mesh for powders—are dialed in order to facilitate reproducible blending with excipients and other actives. We do not just target numbers; every production run gets full-release quality control, which can include polymorph assessments and impurity profiling as demanded by our most sensitive customers, especially those formulating for small companion animals or specialty livestock applications.
Over the years, technical dialogue with formulation scientists guided adjustments to specification sheets. Aqueous stability matters for solution and injectable blends, so our BHT stays free from oxidized byproducts, with peroxide values held under strict control through antioxidant handling protocols. We design moisture packaging and validate transport to ensure that nothing changes between our release and your warehouse receipt. Annual internal audits and external inspections mean our standards do not drift. Our team converts real-world process feedback straight into operational improvements, sharpening lot-to-lot reproducibility.
Our real achievement in BHT manufacturing boils down to reliability. Pharmaceutical and veterinary businesses relying on us care about one thing—can they trust each drum to deliver exactly what the label promises, time after time? BHT acts as an antioxidant, directly protecting vitamins, fats, active agents, and premix ingredients from degradation triggered by exposure to atmospheric oxygen. In our experience, veterinary products face harsher conditions than many human-use drugs—field storage in variable climates, mixed feed and water use, and long shelf-life requirements. Formulators dealing with premixes for mass animal feed often explain how minor anti-oxidant variation can swing shelf-life forecasts by months.
We have supplied injectable and water-soluble forms for years. Every batch serves a blend of local and export markets, with strict adherence to the documented regulatory references. Our participation in custom R&D pilot trials for new solution or injectable blends underscores the core role that a high-grade BHT plays in stabilizing sensitive veterinary APIs. From our end, we see feed and injectable production sites running much smoother when they have predictable antioxidant protection. Medicines hold potency, and product uniformity translates into healthy herds and flocks.
We know the difficulties of working with antioxidants in bulk production. BHT is a phenolic antioxidant, reactive towards oxygen and heat—so problems start when there’s even a slight lapse in air- or moisture-control during synthesis, packaging, or warehousing. Impurities climb and color or odor can shift. There’s no hand-waving these issues away; only thorough process validation, closed-system handling, and environmental controls deliver pharmaceutical-grade stability. In our earliest years, we learned hard lessons about the risks of shortcutting transfer systems or overestimating shelf-stability. Since then, our shop floors run under positive air pressure, workers are trained and evaluated on both product and system hygiene, and every critical step is logged for later review.
Powders for premixes often demand micronization, but too fine a product creates dust and handling losses. We tailor particle size at the point of production to match feedback from major premix houses. Tablets need a crystalline form that compresses well and releases BHT on spec, so we check each lot with in-house compaction simulation. Injectable and solution needs run differently—here, trace moisture or residual solvents can cause huge headaches. Our manufacturing tracks water content and solvent residues to meet international guidelines, and we regularly update internal procedures as global standards evolve.
We often get asked what sets our veterinary-grade BHT apart from commodity or food-grade offerings. The differences begin at raw material sourcing and extend through process control. Food and industrial grades do not meet the same impurity profiles or consistency needs. Veterinary tablet, injection, and capsule manufacturers need assurance that each gram of BHT performs as modeled—color, melting point, chemical identity must land within tight limits. Feed and industrial blends might tolerate more lot-to-lot drift and broader solubility characteristics.
From our own quality assurance audits, we see that food and technical grades sometimes include by-products at the percent level rather than the single-digit ppm values that veterinary APIs demand. These seemingly minor impurities change solubility, degradation tendency, and ultimately the safety of the finished product. For injectable forms especially, trace heavy metals and organic impurities must stay far below feed-level thresholds. Years of working directly with regulatory inspectors means our team doesn’t make assumptions or cut corners: we sample every few hundred kilos, run extra screens for trace impurities, and document all corrective actions and change controls.
We also build long-term stability data specific to each veterinary application. The regulatory landscape expects justification for shelf-life claims that go beyond food-grade documentation. We hold back retention samples from every lot, running stability studies under controlled conditions to monitor for degradation pathways specific to animal applications, such as those triggered by exposure to water-based carriers or multi-feed blending. Veterinary BHT APIs come with a package of verified, regulatory-inspected documentation—conforming to pharmacopeial standards and supporting your own downstream product registration needs.
Our plant produces BHT for every type of veterinary formulation. We’ve worked with partners developing solid oral dosages—tablets, capsules, powders, and granules—with each demanding specific physical properties from the API. Tableting processes do not forgive uncontrolled particle size or off-specification moisture, so every lot gets sieved and tested for compression properties. Powders for direct feed applications need balanced flowability and resistance to caking; we handle anti-caking agents and silica controls meticulously, learning from supply chain feedback every quarter.
Customers producing premix products often ask us for custom particle profiles and packaging options, knowing the direct impact of such choices on downstream blendability. Our team has set up dedicated dry rooms with dehumidified air to ensure packaging and loading stay within moisture specifications. Every process improvement arises from a mix of direct plant observation, customer processing feedback, and laboratory trialing.
Injectables, solutions, and water-dispersible forms place even stricter demands on purity, solubility, and stability. We routinely run compatibility and forced degradation tests, checking stability in simulated product environments. It is not enough for a batch to pass initial purity metrics; it must demonstrate resistance to oxidative change in multi-dose vials or liquid premix solutions. In feedback cycles with formulation teams, we have adopted package solutions that block light, limit air ingress, and simplify end-user handling.
From a manufacturer’s view, specifications cannot simply reflect abstract standards. Our work with real-world veterinary operations forces us to translate analytic data into results animal health experts can trust. No one working farm needs downtime from instability or unpredictability in animal medication. We design each manufacturing step to support the day-in, day-out demands of rapid formulation, consistent mixing, and reliable administration.
Trust at the product level starts with traceability. Each batch receives a unique identifier tracked from incoming raw materials to released API, with detailed documentation covering production conditions, QA release data, and stability status. We maintain full audit trails and stand ready for inspections—both scheduled and unannounced—from veterinary health authorities across several jurisdictions. Our quality team draws on years of preparing authentic data packages, supporting new registration dossiers for global and local animal medicinal authorities, and maintaining Good Manufacturing Practice certification.
Veterinary APIs demand more than traditional chemical controls; they require documentation and testing of antimicrobial, toxicological, and environmental endpoints when needed. Our production facility maintains in-house archives of key regulatory references and works with specialty labs for outside validation. Our team supports direct Q&A during audits, always willing to document or demonstrate the actual production process for customers or regulators on request.
We run mock recalls annually to continuously test the reporting and rapid-response systems needed if quality concerns ever arise. Customers relying on our BHT for injectable or high-value livestock applications benefit from robust complaint resolution and after-sales support processes; real people with practical manufacturing backgrounds answer questions. This direct communication supports confidence through every stage—from new product launch through multi-year supply relationships.
Supplying consistent veterinary BHT APIs involves navigating shifts in raw material markets, regulatory updates, and evolving formulation needs. We have invested in backup raw material contracts and hold safety stocks of API to buffer against supply interruptions. Market volatility taught us the value of redundancy in logistics—our team includes staff solely focused on maintaining cold-chain and ambient shipping routes for both domestic and international customers. Documentation for export customers spans batch-specific COAs, logged transport records, and compatibility certificates when shipping with temperature- or humidity-sensitive veterinary actives.
We monitor international trends in authorized BHT levels, especially as new research appears on safety and exposure limits for food-producing animals. Our technical team surveys literature and regulatory bulletins, updating product dossiers and labelling as necessary to keep customers ahead of change. Ongoing dialogue with veterinary formulators enables us to anticipate requests for more granular purity analysis, new stability data, or innovative dosage forms compatible with latest animal nutrition and medication standards.
The chemical industry faces growing scrutiny regarding environmental and worker safety. Our BHT manufacturing lines operate within closed systems, regularly audited for solvent emissions, dust control, and waste handling. We design our process to minimize off-grade material, recycling wherever possible to conserve input resources and reduce environmental burden. Workers receive ongoing safety training in antioxidant handling and warehouse practices—no shortcut is worth risking health or contamination.
Veterinary products introduce an extra dimension: proper product stewardship to prevent environmental release in the field. We actively cooperate with customers in the downstream supply chain to promote safe disposal and minimize animal exposure risk, all consistent with regulatory and environmental guidance. By focusing on process control and packaging integrity, we help ensure that BHT’s protective benefits land only where needed, not in the broader environment.
Supplying BHT as a veterinary API does not hinge solely on bulk output or meeting baseline compliance checks. Formulation trends shift year by year, and regulatory demands never stand still. Our company backs every order with human technical resources—scientists, process engineers, field liaison staff—who have walked plant floors, solved production headaches, and matched product to need. That commitment to technical detail means more than polished bullet points: each improvement in impurity reduction or packaging design stems from lessons learned alongside real customers.
The next generation of veterinary drugs and animal feed products will require even sharper analytical support, coupled with sustainable practices and resilient supply chains. Our production staff focus on continuous improvement, investing in both people and process to stay ahead of evolving standards. We know our position at the foundation of animal healthcare supply—every lot of BHT must serve with consistency, safety, and proven stability or nothing else matters.
From the perspective of long-term production teams, the best products reflect both technical competence and an open door between manufacturer and formulation expert. Our BHT, produced for veterinary API applications, serves as the quiet backbone for countless animal health products, and we approach every lot with the seriousness that responsibility deserves.